Selling Your Dental Practice
If you want to sell your dental practice, a confidential advisor-run process — not a listing on a practice-transition board — is what creates competitive tension among vetted DSO, private-equity, and dentist buyers. Understand what your practice is worth, who is buying in 2026, and how a sell-side process protects your value.
Inquiries are strictly confidential — no public listing of your firm.
A listing is not a process
Search "dental practice for sale" and you will find practice-transition brokers and listing boards. Posting your practice to a board is not the same as running a sell-side process — and the difference shows up in your final number, especially when DSO and private-equity buyers are competing.
5x – 11x adjusted EBITDA
smaller single-location practices often price closer to 5x–7x, while multi-site groups and platform-grade practices (roughly $2M+ EBITDA) reach 9x–11x and above; specialty groups such as orthodontics and pediatric dentistry can command a further premium
Who is buying dental practices in 2026
The buyer universe for dental practices is dominated by well-capitalized consolidators. Dental support organizations (DSOs) backed by private equity are actively acquiring practices for scale, and that competition is exactly why associate-led, hygiene-heavy practices are being bid up.
Ownership, licensing & the corporate practice of dentistry
Many states enforce corporate-practice-of-dentistry rules that require clinical dentistry to be owned by a licensed dentist, which is precisely why DSOs use a management services organization (MSO) model: the DSO owns the non-clinical business and provides management services, while a licensed dentist retains the professional (clinical) entity. This structure — plus dental-license transfer, patient-record custody under HIPAA, and any Medicaid/insurance provider re-credentialing — shapes how your deal must be papered. Requirements vary by state, so ownership and MSO structure should be confirmed with qualified legal and tax counsel before going to market. This overview is general information, not legal advice.
DSO platforms & consolidators
Dental support organizations acquiring for scale, purchasing power, and back-office leverage — Heartland Dental (backed by KKR), Aspen Dental (backed by Leonard Green), MB2 Dental, and Pacific Dental Services are among the most active platforms. Deals are typically structured through a management services organization (MSO): the DSO buys the non-clinical assets and manages operations, while a licensed dentist retains clinical ownership. Expect equity rollover and post-close production commitments, not a clean walk-away exit.
Private-equity sponsors
Sponsors either building a new dental platform or funding an existing DSO's add-on acquisitions. They value durable hygiene revenue, associate-driven production, and a practice that can absorb the platform's systems. MB2 Dental's recapitalization with Warburg Pincus is a clear signal of continued sponsor appetite in the space.
Individual-dentist succession
A single dentist or an associate already in the practice acquiring it for succession, often with bank or SBA financing. Best fit for smaller, owner-dependent practices with a clear transition runway and a buyer who can hold the required clinical license.
MB2 Dental — a dentist-owned partnership model supporting hundreds of affiliated practices — announced a recapitalization with new investor Warburg Pincus, a $525 million investment at a total enterprise value in excess of $3.5 billion, with existing investor Charlesbank Capital Partners remaining a partner.
A high-profile example of private equity re-underwriting a large DSO at scale and offering liquidity to partner dentists. Proof that capital is chasing platform-grade dental groups — and that affiliating rather than simply selling outright is now a core deal structure.
How a sell-side process works, end to end
A structured process is what turns "I got a call from a DSO" into "I ran a market and chose the best partner." Each stage is designed to protect your confidentiality and your leverage.
- 013–5 weeks
Preparation & positioning
Normalize financials, add back owner-dentist compensation and personal expenses, and frame the hygiene mix and associate-led production story that moves your multiple.
- 021–2 weeks
Valuation & strategy
Establish a defensible value range and target the right buyer archetype — DSO platform, PE sponsor, or dentist succession.
- 034–6 weeks
Confidential buyer outreach
Approach a curated set of vetted buyers under NDA. No public listing, no exposure to patients or staff.
- 042–4 weeks
Offers & LOI
Drive competitive tension to a deadline, compare MSO and rollover structures side by side, and negotiate the letter of intent.
- 054–8 weeks
Diligence
Manage the buyer's financial, clinical, and quality-of-earnings review — production reports, payer mix, hygiene metrics, and staff retention — while keeping the deal on track.
- 062–4 weeks
Close & transition
Finalize terms, fund, transfer patient records under HIPAA, and execute the retention/transition plan that keeps patients, hygienists, and associates in place.
Deal structures owners should understand
Most dental deals are not all-cash at close. Knowing the levers in advance is how you avoid leaving value — or protection — on the table.
MSO / DSO affiliation
The buyer forms a management services organization that acquires the practice's non-clinical assets and handles operations, while a licensed dentist retains the clinical entity. Understanding this split is essential to comparing DSO offers accurately.
Equity rollover
Reinvesting part of your proceeds into the DSO or platform — a "second bite" if the platform grows and sells again. Standard in DSO partnership structures and often a meaningful share of total value.
Post-close employment & production
DSO buyers price in your continued clinical work for a defined term, frequently with a production or collections target. Length and compensation are negotiable and material to your net outcome.
Asset vs. equity sale
Whether the buyer purchases the practice's assets or the entity itself changes tax treatment and liability — a decision worth modeling before you go to market.
What to fix before you go to market
The same levers buyers price are the ones you can move beforehand. Addressing them early is the highest-ROI work a dentist can do before a sale.
Reduce owner-dentist dependence
Buyers discount practices that revolve around one clinician. Adding productive associates and distributing patient relationships shows the practice runs — and produces — without you.
Strengthen hygiene revenue
A healthy hygiene share (well above roughly 30% of production) signals recurring, recall-driven revenue — one of the highest-leverage drivers of a premium dental multiple.
Retain associates and hygienists
Continuity of clinical and hygiene staff protects the patient base and production through transition. Employment agreements and non-competes reassure buyers.
Clean up records and payer mix
Organized, transferable patient records, clear production reports, and a documented payer/insurance mix make diligence faster and defend your valuation.
Frequently asked questions
Through a confidential sell-side process: prepare and value the practice, approach vetted DSO, private-equity, and dentist buyers under NDA, drive competitive offers, negotiate the LOI, and manage diligence to close. The goal is to run a market rather than accept a single inbound offer from one DSO.
Dental practices commonly sell for roughly 5x–11x adjusted EBITDA in 2026, with smaller single-location practices nearer 5x–7x and multi-site, platform-grade groups reaching 9x–11x or more. Hygiene revenue mix, associate-led production, and owner dependence drive where you land. Start with our valuation tool to see your range.
DSO platforms and consolidators (such as Heartland Dental, Aspen Dental, MB2 Dental, and Pacific Dental Services), private-equity sponsors building or funding platforms, and individual dentists acquiring for succession. In 2026, PE-backed DSOs are the most active buyers, usually structuring deals through an MSO with equity rollover.
A well-run sell-side process typically runs four to seven months from preparation to close, depending on practice size, diligence complexity, and the transition plan.
Usually for a defined period. DSO and PE buyers typically price in continued clinical work under a post-close employment agreement, often with a production target, to protect patient retention. The length and compensation are negotiable and are a core part of what a sell-side advisor negotiates for you.
Start a confidential valuation conversation
No public listing, no upfront fees. Understand what your dental practice is worth and what a real sell-side process could deliver. 100% success fee · $0 upfront · $1B+ closed.